Jointly sponsored by the National Lung Cancer Partnership and Research To Practice
Home
Patient Interviews
Clinician Interviews
About Us
Contact Us
Understanding Lung Cancer
Risks for Developing Lung Cancer
Defining Types of Lung Cancer, Stage and When to Use Adjuvant Therapy
Dealing with a Diagnosis of Lung Cancer
Coping with Lung Cancer
Advice from Health Care Professionals
Advice from Survivors and Patients
Exploring Treatment Options
Introduction to Adjuvant Therapy
Adjuvant Therapy Options After Surgery
Deciding on Adjuvant Therapy Options (Including Clinical Trials)
Side Effects Associated with Different Chemotherapies
Introduction to Targeted Therapies
Side Effects Associated with Targeted Therapies
Participating in Clinical Trials
Currently Available Clinical Trials for Early Stage Lung Cancer
Enrolling in a Clinical Trial
Clinical Trials Evaluating Targeted Therapies
Clinical Trials Evaluating Targeted Therapies
Clinical Trials Evaluating Targeted Agents in the Adjuvant Setting
Interview with Dr Wakelee
Clinical Trials evaluating targeted agents in the adjuvant setting
ECOG-E1505: A clinical trial evaluating chemotherapy with or without bevacizumab
Interview with Dr Schiller
Radiant: A clinical trial evaluating erlotinib with chemotherapy
NSABP-C-08: Results of a colorectal cancer trial with bevacizumab in the Adjuvant setting
Interview with Ms Eaby
EGFR mutations and treatment indications